Clean Cells, Naobios step up Asia expansion at BIO KOREA 2026 in Seoul

The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem

GlycoNex wins Japan nod to launch first human trial of lead program in gastrointestinal cancers

The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy

Dr Jitendra Singh stresses strong clinical foundations in medical education amid AI expansion

At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning

FDA clears Travere’s FILSPARI for expanded use in rare kidney disease

Thermo Fisher and Singapore’s PRECISE launch major proteomics push in 100,000-person study

The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation

Roche wins CE mark for blood-based MS brain damage test

The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain

C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality

The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation

Revvity launches Signals BioDesign to transform molecular cloning

The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application

Moderna to reveal late-breaking data on flu & RSV mRNA vax at ESCMID 2026

The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21

Experts advocate holistic Semaglutide use as therapy goes off patent in India

They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market